Post-IPO Equity - Generation Bio

Post-IPO Equity - Generation Bio

Investment Firm

Overview

Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.

Announced Date

Mar 23, 2023

Funding Type

Post Ipo Equity

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Moderna

Moderna

Moderna is a seed firm.

Participant Investors

1

Investor Name
Participant InvestorModerna

Round Details and Background

Generation Bio raised $76000000 on 2023-03-23 in Post-IPO Equity

Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 27, 2018
Series B - Generation Bio
6-100.0M
Jan 10, 2020
Series C - Generation Bio
9-110.0M
Jan 06, 2021
Post-IPO Equity - Generation Bio
-225.4M
Mar 23, 2023
Post-IPO Equity - Generation Bio
1-76.0M

Recent Activity

There is no recent news or activity for this profile.